Results 161 to 170 of about 26,529 (243)

Nano‐Backpack Engineered Probiotics with Reactive Oxygen Species–Responsive Tungsten Release for Synergistic Therapy of Inflammatory Bowel Disease

open access: yesAdvanced Science, Volume 13, Issue 52, 18 September 2026.
An integrated probiotic system is engineered to execute a programmed therapeutic cascade against inflammatory bowel disease. Upon pathological signals, the system sequentially performs ROS scavenging, tungsten release, and selective pathogen suppression, thereby breaking the oxidative stress–dysbiosis cycle to remodel gut microbiota and reinforce ...
Yang Yang   +8 more
wiley   +1 more source

A Practical Gut‐On‐Chip Workflow for Imaging‐Based Assessment of Epithelial Barrier Dynamics During E. coli Co‐Culture

open access: yesBiotechnology and Bioengineering, Volume 123, Issue 9, Page 2238-2247, September 2026.
ABSTRACT The intestinal epithelium and its resident microbiota form a dynamic interface that is central to gut homeostasis, but this interface is difficult to model with conventional tools. Static Transwell cultures lack physiological fluid shear, whereas animal models are costly and poorly suited to quantitative, high‐content imaging.
Shih‐Wei Chiang   +2 more
wiley   +1 more source

Anaerobe-Driven Inflammation and Epithelial Barrier Disruption in Genital HIV Acquisition. [PDF]

open access: yesAm J Reprod Immunol
Constable S   +6 more
europepmc   +1 more source

Concomitant Lemierre's Syndrome and Base‐of‐Skull Osteomyelitis Caused by Arcanobacterium haemolyticum, Complicated by Ceftriaxone‐Associated Cholecystitis: A Case Report

open access: yesClinical Case Reports, Volume 14, Issue 9, September 2026.
ABSTRACT Lemierre's syndrome and base‐of‐skull osteomyelitis can occur together in immunocompetent adolescents with Arcanobacterium haemolyticum bacteraemia. Prolonged high‐dose ceftriaxone may precipitate symptomatic cholecystitis. Clinicians should consider A.
Angus Lane, Alexandra Stewart
wiley   +1 more source

Modulating the Gut‐Microbiota‐Brain Axis in Alzheimer's Disease: Therapeutic Potential of Nutritional and Metabolic Factors

open access: yesCNS Neuroscience &Therapeutics, Volume 32, Issue 9, September 2026.
This review systematically examines the role of gut microbiota modulation in Alzheimer's disease, focusing on how microbial metabolites and dietary nutrients influence cognitive function and AD pathology, as well as the neuroprotective effects through the gut‐brain axis.
Binyue Xu   +6 more
wiley   +1 more source

Microbial species in deep tissue lesions of Hurley stage III hidradenitis suppurativa: a retrospective observational study. [PDF]

open access: yesBMC Microbiol
Stanton WN   +7 more
europepmc   +1 more source

Standardized In‐house Protocol for Determining the Minimum Inhibitory Concentration (MIC) via Broth Microdilution for Natural Products Against Obligate Anaerobic Bacteria

open access: yesCurrent Protocols, Volume 6, Issue 9, September 2026.
Abstract Obligate anaerobic bacteria are important constituents of the human microbiota and are frequently involved in opportunistic infections. However, due to their fastidious nature and oxygen sensitivity, antimicrobial susceptibility testing (AST) is often neglected, resulting in empirical treatments and an increased risk of therapeutic failure ...
Daniela Silva Gonçalves   +3 more
wiley   +1 more source

Rethinking Vaginal Microbiome Resilience: A Conceptual Multi-Omic Framework. [PDF]

open access: yesMicroorganisms
Cagle-White B   +4 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy